C (Metformin Hydrochloride Extended Release Tablets 1)
Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 65162-178
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 65162-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
A (Metformin Hydrochloride Extended Release Tablets 2)
This is a description of a medication that is Metformin Hydrochloride Extended-release Tablets, USP. Each tablet contains 500mg of Metformin Hydrochloride, and usual dosage instructions can be found in the enclosed package insert. The tablets should be stored in a tight, light-resistant container at a temperature between 20" to 25°C. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The NDC number is 65162-178-10.*
B (Metformin Hydrochloride Extended Release Tablets 3)
The text describes Metformin Hydrochloride extended-release tablets, used for treating type 2 diabetes. The tablets come in a tight and light-resistant packaging along with a patient information leaflet. The usual dosage is mentioned in an enclosed package insert. The tablets should be stored at a temperature between 20°C to 25°C, and excursions are permitted between 15°C to 30°C. The tablets are manufactured by Amneal Pharmaceuticals located in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC located in Bridgewater, NJ. No further information is available from the given text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
